Orphapacket:
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Antenatal
  - AverageAgeOfOnset:
      value: Childhood
  - AverageAgeOfOnset:
      value: Infancy
  Children: []
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
    Reference: '180200'
    Source: OMIM
  Label: Retinoblastoma
  ORPHAcode: '790'
  ORPHApacketId: '790'
  PURL: http://www.orpha.net/ORDO/Orphanet_790
  Parents:
  - Parent:
    - Label: Rare ophthalmic disorder
      ORPHAcode: '97966'
  - Parent:
    - Label: Rare eye tumor
      ORPHAcode: '101950'
  - Parent:
    - Label: Pediatric eye cancer
      ORPHAcode: '602699'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Obligate (100%)
      HPOId: HP:0009919
      HPOTerm: Retinoblastoma
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000486
      HPOTerm: Strabismus
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000501
      HPOTerm: Glaucoma
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000520
      HPOTerm: Proptosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000555
      HPOTerm: Leukocoria
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0031615
      HPOTerm: Hypopyon
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000554
      HPOTerm: Uveitis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001100
      HPOTerm: Heterochromia iridis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001909
      HPOTerm: Leukemia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002665
      HPOTerm: Lymphoma
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002669
      HPOTerm: Osteosarcoma
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002859
      HPOTerm: Rhabdomyosarcoma
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002861
      HPOTerm: Melanoma
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0007663
      HPOTerm: Reduced visual acuity
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0007703
      HPOTerm: Abnormality of retinal pigmentation
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0007862
      HPOTerm: Retinal calcification
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0007902
      HPOTerm: Vitreous hemorrhage
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0011886
      HPOTerm: Hyphema
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0012372
      HPOTerm: Abnormal eye morphology
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0025244
      HPOTerm: Subretinal pigment epithelium hemorrhage
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0025337
      HPOTerm: Red eye
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0100243
      HPOTerm: Leiomyosarcoma
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0100658
      HPOTerm: Cellulitis
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0000175
      HPOTerm: Cleft palate
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0009733
      HPOTerm: Glioma
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0012254
      HPOTerm: Ewing sarcoma
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0030408
      HPOTerm: Pineoblastoma
  Prevalences:
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 19373260[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Korea, Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 24692122[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Lifetime Prevalence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 22414599[PMID]_19704035[PMID]_ [EXPERT]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 1513060[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: Unknown
      PrevalenceGeographic: Europe
      PrevalenceQualification: Class only
      PrevalenceType: Point prevalence
      Source: ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Belgium
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Bulgaria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Croatia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Latvia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Lithuania
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Malta
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Slovakia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Slovenia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Switzerland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  TextSection:
    Contents: A rare eye tumor disease representing the most common intraocular malignancy
      in children. It is a life threatening neoplasia but is potentially curable and
      it can be hereditary or non hereditary unilateral or bilateral.
    TextSectionType: Definition
  TypeOfInheritances:
  - TypeOfInheritance:
      value: Autosomal dominant
  - TypeOfInheritance:
      value: Not applicable
  copyright: Orphanet (c) 2025
  creationDate: '2025-12-09 10:41:42'
  version: 1.3.42 / 4.1.8 [2025-03-03]
